122 related articles for article (PubMed ID: 2470928)
1. Prostatic specific antigen: immunoreactivity in urachal remnants.
Golz R; Schubert GE
J Urol; 1989 Jun; 141(6):1480-2. PubMed ID: 2470928
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.
McEntee M; Isaacs W; Smith C
Prostate; 1987; 11(2):163-70. PubMed ID: 2444955
[TBL] [Abstract][Full Text] [Related]
3. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J
Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
[TBL] [Abstract][Full Text] [Related]
4. Re: Prostatic specific antigen: immunoreactivity in urachal remnants.
Flood HD; Gaffney EF
J Urol; 1990 Nov; 144(5):1244. PubMed ID: 1700146
[No Abstract] [Full Text] [Related]
5. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
Rainwater LM; Morgan WR; Klee GG; Zincke H
Mayo Clin Proc; 1990 Aug; 65(8):1118-26. PubMed ID: 1697014
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
8. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas.
Myers RB; Meredith RF; Schlom J; LoBuglio AF; Bueschen AJ; Wheeler RH; Stockard CR; Grizzle WE
J Urol; 1994 Jul; 152(1):243-6. PubMed ID: 8201675
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the prostate involving 2 cell types (prostate specific antigen producing and carcinoembryonic antigen producing) with selective metastatic spread.
Guthman DA; Farrow GM; Myers RP; Ferrigni RG; Lieber MM
J Urol; 1991 Sep; 146(3):854-6. PubMed ID: 1714970
[TBL] [Abstract][Full Text] [Related]
10. Immunoperoxidase localization of prostate-specific antigen.
Stein BS; Vangore S; Petersen RO; Kendall AR
Am J Surg Pathol; 1982 Sep; 6(6):553-7. PubMed ID: 6183983
[TBL] [Abstract][Full Text] [Related]
11. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
12. Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
Rizk CC; Scholes J; Chen SK; Ward J; Romas NA
Urology; 1990 Dec; 36(6):526-30. PubMed ID: 1701066
[TBL] [Abstract][Full Text] [Related]
13. Nonspecificity of colon-specific antigen in adenocarcinomas. An immunohistochemical study of 422 cases.
Loy TS; Chapman RK; White L; Diaz-Arias AA; Bickel JT
Am J Clin Pathol; 1992 Apr; 97(4):490-2. PubMed ID: 1553913
[TBL] [Abstract][Full Text] [Related]
14. [The value of histochemical detection of prostate specific antigen].
Hashimoto H; Yachiku S; Nishihara M; Arima S; Tokunaka S; Inada F
Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1319-22. PubMed ID: 2449558
[No Abstract] [Full Text] [Related]
15. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
17. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
Oesterling JE; Chan DW; Epstein JI; Kimball AW; Bruzek DJ; Rock RC; Brendler CB; Walsh PC
J Urol; 1988 Apr; 139(4):766-72. PubMed ID: 2451037
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of prostatic acid phosphatase and prostatic specific antigen in prostatic carcinoma--a comparison of monoclonal antibody to polyclonal antibody].
Moriyama N; Taniguchi J; Hara M; Fukutani K; Matsushima H; Murakami T; Isurugi K; Kawabe K; Niijima T
Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):1992-7. PubMed ID: 2453695
[No Abstract] [Full Text] [Related]
19. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
Oesterling JE
J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical detection of prostate carcinoma].
Ma WX; Li W
Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):37-9. PubMed ID: 2476252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]